This program project is a multidisciplinary approach to study the prevalence, natural history and pathogenesis of human papillomavirus (HPV) infections of the genital tract. Recent evidence suggests that infection with the genital HPV types, i.e., 6,11,16,18,31,33 etc., is widespread in the population and that asymptomatic infection with these viruses may be a common occurrence of childhood. Four projects are proposed: The first project focuses on perinatal and childhood transmission of HPVs. Women will be monitored throughout pregnancy and during the post partum period. The babies will be monitored at birth and during regularly scheduled infant/childhood exams. In addition partners of the mothers and other siblings in the family will be studied. Assessment of HPV infection will be made by both detection of viral DNA, and by serologic assays. The second project focuses on the rate of acquisition and the risk factors associated with HPV infection in college women who are initiating sexual activity. The third project is to characterize the humoral immune response to HPV infection. Using newly developed serologic assays the prevalence of HPV infection will be determined in the above populations. The patterns of antibody response to various viral antigens will be investigated and correlated with the clinical findings. The fourth project focuses on the pathogenesis of HPV infection by investigating at the molecular and cellular level the nature of the interaction between HPVs and various types of epithelial cells to better understand the in vivo behavior of the virus. The projects will be supported by four cores which will analyze samples for HPV DNA (by PCR, Southern blot and Virapap), perform cytologic and histologic analyses, provide data management and biostatistical analysis, and coordinate administrative functions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI029363-03
Application #
3092041
Study Section
Special Emphasis Panel (SRC (90))
Project Start
1990-04-01
Project End
1995-03-31
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
3
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Watts, D H; Koutsky, L A; Holmes, K K et al. (1998) Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. Am J Obstet Gynecol 178:365-73
Carter, J J; Koutsky, L A; Wipf, G C et al. (1996) The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J Infect Dis 174:927-36
Hagensee, M E; Carter, J J; Wipf, G C et al. (1995) Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies. Virology 206:174-82
Ostrow, R S; Coughlin, S M; McGlennen, R C et al. (1995) Serological and molecular evidence of rhesus papillomavirus type 1 infections in tissues from geographically distinct institutions. J Gen Virol 76 ( Pt 2):293-9
Baken, L A; Koutsky, L A; Kuypers, J et al. (1995) Genital human papillomavirus infection among male and female sex partners: prevalence and type-specific concordance. J Infect Dis 171:429-32
Xi, L F; Demers, G W; Koutsky, L A et al. (1995) Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J Infect Dis 172:747-55
Carter, J J; Hagensee, M B; Lee, S K et al. (1994) Use of HPV 1 capsids produced by recombinant vaccinia viruses in an ELISA to detect serum antibodies in people with foot warts. Virology 199:284-91
McDougall, J K (1994) Immortalization and transformation of human cells by human papillomavirus. Curr Top Microbiol Immunol 186:101-19
Xi, L F; Demers, W; Kiviat, N B et al. (1993) Sequence variation in the noncoding region of human papillomavirus type 16 detected by single-strand conformation polymorphism analysis. J Infect Dis 168:610-7
Merrick, D T; Gown, A M; Halbert, C L et al. (1993) Human papillomavirus-immortalized keratinocytes are resistant to the effects of retinoic acid on terminal differentiation. Cell Growth Differ 4:831-40

Showing the most recent 10 out of 17 publications